Individualized treatment should be performed in the immune-tolerant phase of hepatitis B virus infection

Bibliographic Details
Main Author: CUI Zixin
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2021-06-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.06.009
id doaj-8cfda60cec8244e1ab8ddea8f34ca15a
record_format Article
spelling doaj-8cfda60cec8244e1ab8ddea8f34ca15a2021-06-24T02:43:47ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562021-06-0137612771277Individualized treatment should be performed in the immune-tolerant phase of hepatitis B virus infectionCUI Zixin0The First Affiliated Hospital of Xi’an Jiaotong Universityhttp://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.06.009
collection DOAJ
language zho
format Article
sources DOAJ
author CUI Zixin
spellingShingle CUI Zixin
Individualized treatment should be performed in the immune-tolerant phase of hepatitis B virus infection
Linchuang Gandanbing Zazhi
author_facet CUI Zixin
author_sort CUI Zixin
title Individualized treatment should be performed in the immune-tolerant phase of hepatitis B virus infection
title_short Individualized treatment should be performed in the immune-tolerant phase of hepatitis B virus infection
title_full Individualized treatment should be performed in the immune-tolerant phase of hepatitis B virus infection
title_fullStr Individualized treatment should be performed in the immune-tolerant phase of hepatitis B virus infection
title_full_unstemmed Individualized treatment should be performed in the immune-tolerant phase of hepatitis B virus infection
title_sort individualized treatment should be performed in the immune-tolerant phase of hepatitis b virus infection
publisher Editorial Department of Journal of Clinical Hepatology
series Linchuang Gandanbing Zazhi
issn 1001-5256
1001-5256
publishDate 2021-06-01
url http://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.06.009
work_keys_str_mv AT cuizixin individualizedtreatmentshouldbeperformedintheimmunetolerantphaseofhepatitisbvirusinfection
_version_ 1721361824702529536